Pharmaceuticals Companies By Five Year Return
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Five Year Return
| Five Year Return | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | VRNA | Verona Pharma PLC | 0.16 | 3.75 | 0.62 | ||
| 2 | ITCI | Intracellular Th | 0.17 | 4.80 | 0.83 | ||
| 3 | HROW | Harrow Health | (0.06) | 4.13 | (0.24) | ||
| 4 | LLY | Eli Lilly and | 0.06 | 2.06 | 0.11 | ||
| 5 | CORT | Corcept Therapeutics Incorporated | 0.06 | 3.58 | 0.20 | ||
| 6 | LQDA | Liquidia Technologies | 0.17 | 2.69 | 0.45 | ||
| 7 | ETON | Eton Pharmaceuticals | 0.03 | 4.81 | 0.16 | ||
| 8 | EOLS | Evolus Inc | 0.06 | 4.83 | 0.29 | ||
| 9 | TRVI | Trevi Therapeutics | 0.14 | 6.43 | 0.87 | ||
| 10 | AMRX | Amneal Pharmaceuticals, Class | 0.08 | 2.05 | 0.17 | ||
| 11 | XERS | Xeris Pharmaceuticals | 0.28 | 3.17 | 0.90 | ||
| 12 | NVO | Novo Nordisk AS | (0.10) | 2.86 | (0.29) | ||
| 13 | TARS | Tarsus Pharmaceuticals | (0.02) | 3.57 | (0.06) | ||
| 14 | PBH | Prestige Brand Holdings | 0.07 | 2.38 | 0.16 | ||
| 15 | BGM | Qilian International Holding | 0.09 | 7.41 | 0.70 | ||
| 16 | TEVA | Teva Pharma Industries | (0.20) | 2.86 | (0.58) | ||
| 17 | AMPH | Amphastar P | (0.19) | 2.33 | (0.45) | ||
| 18 | SUPN | Supernus Pharmaceuticals | (0.07) | 2.69 | (0.19) | ||
| 19 | CRMD | CorMedix | 0.00 | 6.81 | 0.01 | ||
| 20 | AXSM | Axsome Therapeutics | 0.15 | 4.17 | 0.61 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions. Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.